Factors and molecular mechanisms of radiation resistance in cancer cells

References

• Ahmad P, Sana J, Slavik M, Slampa P, Smilek P, Slaby O. 2017. MicroRNAs involvement in radioresistance of head and neck cancer. Dis Markers. 2017:8245345.
   PubMed Web of Science ®Google Scholar
• Ashrafizadeh M, Farhood B, Eleojo Musa A, Taeb S, Najafi M. 2020. Damage-associated molecular patterns in tumor radiotherapy. Int Immunopharmacol. 86:106761.
   PubMed Web of Science ®Google Scholar
• Baek JH, Lee J, Yun HS, Lee CW, Song JY, Um HD, Park JK, Park IC, Kim JS, Kim EH, et al. 2018. Kinesin light chain-4 depletion induces apoptosis of radioresistant cancer cells by mitochondrial dysfunction via calcium ion influx. Cell Death Dis. 9(5):496.
   PubMedGoogle Scholar
• Bamodu OA, Bamodu OA, Chang HL, Ong JR, Lee WH, Yeh CT, Tsai JT. 2020. Elevated PDK1 expression drives PI3K/AKT/MTOR signaling promotes radiation-resistant and dedifferentiated phenotype of hepatocelullar carcinoma. Cells. 9(3):746.
   PubMed Web of Science ®Google Scholar
• Barker H, Barker HE, Patel R, McLaughlin M, Schick U, Zaidi S, Nutting CM, Newbold KL, Bhide S, Harrington KJ. 2016. CHK1 inhibition radiosensitizes head and neck cancers to paclitaxel-based chemoradiotherapy. Mol Cancer Ther. 15(9):2042–2054.
   PubMed Web of Science ®Google Scholar
• Chae Y, Roh J, Kim W. 2021. The roles played by long non-coding RNAs in glioma resistance. IJMS. 22(13):6834.
   Google Scholar
• Chang L, Chang L, Ni J, Beretov J, Wasinger VC, Hao J, Bucci J, Malouf D, Gillatt D, Graham PH, et al. 2017. Identification of protein biomarkers and signaling pathways associated with prostate cancer radioresistance using label-free LC-MS/MS proteomic approach. Sci Rep. 7:41834.
   PubMed Web of Science ®Google Scholar
• Chang L, Graham P, Hao J, Ni J, Deng J, Bucci J, Malouf D, Gillatt D, Li Y. 2016. Cancer stem cells and signaling pathways in radioresistance. Oncotarget. 7(10):11002–11017.
   PubMedGoogle Scholar
• Chen D, Su H, Li Y, Wu X, Li Y, Wei C, Shi D, Gao Y, Zhou Q, Wang Q, et al. 2021. miR-20b and miR-125a promote tumorigenesis in radioresistant esophageal carcinoma cells. Aging. 13(7):9566–9581.
   PubMedGoogle Scholar
• Ciccarelli C, Vulcano F, Milazzo L, Gravina GL, Marampon F, Macioce G, Giampaolo A, Tombolini V, Di Paolo V, Hassan HJ, et al. 2016. Key Role of MEK/ERK pathway in sustaining tumorigenicity and in vitro radioresistance of embryonal rhabdomyosarcoma stem-like cell population. Mol Cancer. 15:16.
   PubMed Web of Science ®Google Scholar
• Daskalaki W, Wardelmann E, Port M, Stock K, Steinestel J, Huss S, Sperveslage J, Steinestel K, Eder S. 2018. Expression levels of hnRNPK and p21 WAF1/CIP1 are associated with resistance to radiochemotherapy independent of p53 pathway activation in rectal adenocarcinoma. Int J Mol Med. 42:3269–3277.
   PubMed Web of Science ®Google Scholar
• Di L, Zhao X, Ding J. 2021. Knockdown of circ_0008344 contributes to radiosensitization in glioma via miR-433-3p/RNF2 axis. J Biosci. 46(3):82.
   PubMed Web of Science ®Google Scholar
• Eguchi T, Sogawa C, Ono K, Matsumoto M, Tran MT, Okusha Y, Lang BJ, Okamoto K, Calderwood SK. 2020. Cell stress induced stressome release including damaged membrane vesicles and extracellular HSP90 by prostate cancer cells. Cells. 9(3):755.
   Web of Science ®Google Scholar
• Endo S, Fujita M, Yamada S, Imadome K, Nakayama F, Isozaki T, Yasuda T, Imai T, Matsubara H. 2018. Fra‑1 enhances the radioresistance of colon cancer cells to X‑ray or C‑ion radiation . Oncol Rep. 39(3):1112–1118.
   PubMed Web of Science ®Google Scholar
• Ernst BP, Wiesmann N, Gieringer R, Eckrich J, Brieger J. 2020. HSP27 regulates viability and migration of cancer cell lines following irradiation. J Proteomics. 226:103886.
   PubMed Web of Science ®Google Scholar
• Fujiwara S, Wada N, Kawano Y, Okuno Y, Kikukawa Y, Endo S, Nishimura N, Ueno N, Mitsuya H, Hata H. 2015. Lactate, a putative survival factor for myeloma cells, is incorporated by myeloma cells through monocarboxylate transporters 1. Exp Hematol Oncol. 4:12.
   PubMedGoogle Scholar
• Gao Y, Kardos J, Yang Y, Tamir TY, Mutter-Rottmayer E, Weissman B, Major MB, Kim WY, Vaziri C. 2018. The cancer/testes (CT) antigen HORMAD1 promotes homologous recombinational DNA repair and radioresistance in lung adenocarcinoma cells. Sci Rep. 8(1):15304.
   PubMedGoogle Scholar
• Gouazé-Andersson V, Ghérardi MJ, Lemarié A, Gilhodes J, Lubrano V, Arnauduc F, Moyal ECJ, Toulas C. 2018. FGFR1/FOXM1 pathway: a key regulator of glioblastoma stem cells radioresistance and a prognosis biomarker. Oncotarget. 9(60):31637–31649.
   PubMedGoogle Scholar
• Gu H, Huang T, Shen Y, Liu Y, Zhou F, Jin Y, Sattar H, Wei Y. 2018. Reactive oxygen species-mediated tumor microenvironment transformation: the mechanism of radioresistant gastric cancer. Oxid Med Cell Longev. 2018:5801209.
   PubMed Web of Science ®Google Scholar
• He Z, Shen F, Qi P, Zhai Z, Wang Z. 2021. miR-541-3p enhances the radiosensitivity of prostate cancer cells by inhibiting HSP27 expression and downregulating β-catenin. Cell Death Discov. 7(1):18.
   PubMed Web of Science ®Google Scholar
• Huang EY, Chang JC, Chen HH, Hsu CY, Hsu HC, Wu KL. 2018. Carcinoembryonic antigen as a marker of radioresistance in colorectal cancer: a potencial role of macrophages. BMC Cancer. 18(1):321.
   PubMedGoogle Scholar
• Jeong Y, Hoang NT, Lovejoy A, Stehr H, Newman AM, Gentles AJ, Kong W, Truong D, Martin S, Chaudhuri A, et al. 2017. Role of KEAP1/NRF2 and TP53 mutations in lung squamous cell carcinoma development and radiation resistance. Cancer Discov. 7(1):86–101.
   PubMed Web of Science ®Google Scholar
• Jiang W, Jin G, Cai F, Chen X, Cao N, Zhang X, Liu J, Chen F, Wang F, Dong W, et al. 2019. Extracellular signal-regulated kinase 5 increases radioresistance of lung cancer cells by enhancing the DNA damage response. Exp Mol Med. 51(2):1–20.
   Web of Science ®Google Scholar
• Kabakov AE, Gabai VL. 2021. HSP70s in breast cancer: promoters of tumorigenesis and potential targets/tools for therapy. Cells. 10(12):3446.
   PubMed Web of Science ®Google Scholar
• Kabakov AE, Yakimova AO. 2021. Hypoxia-induced cancer cell responses driving radioresistance of hypoxic tumors: approaches to targeting and radiosensitizing. Cancers. 13(5):1102.
   PubMed Web of Science ®Google Scholar
• Kabakov A, Yakimova A, Matchuk O. 2020. Molecular chaperones in cancer stem cells: determinants of stemness and potential targets for antitumor therapy. Cells. 9(4):892.
   PubMed Web of Science ®Google Scholar
• Kaliberov SA, Buchsbaum DJ. 2012. Cancer treatment with gene therapy and radiation therapy. Adv Cancer Res. 115:221–263.
   PubMed Web of Science ®Google Scholar
• Kang J, Kim W, Kwon T, Youn H, Kim JS, Youn B. 2016. Plasminogen activator inhibitor-1 enhances radioresistance and aggressiveness of non-small cell lung cancer cells. Oncotarget. 7(17):23961–23974.
   PubMedGoogle Scholar
• Ketteler J, Panic A, Reis H, Wittka A, Maier P, Herskind C, Yagüe E, Jendrossek V, Klein D. 2019. Progression-related loss of stromal caveolin 1 levels mediates radiatio in resistance in prostate carcinoma via the apoptosis inhibitor TRIAP1. JCM. 8(3):348.
   Google Scholar
• Kim BM, Hong Y, Lee S, Liu P, Lim JH, Lee YH, Lee TH, Chang KT, Hong Y. 2015. Therapeutic implications for overcoming radiation resistance in cancer therapy. Int J Mol Sci. 16:26889–26913.
   Web of Science ®Google Scholar
• Kim EH, Kim MS, Lee KH, Koh JS, Jung WG, Kong CB. 2016. Zoledronic acid is an effective radiosensitizer in the treatment of osteosarcoma. Oncotarget. 7(43):70869–70880.
   PubMedGoogle Scholar
• Kim JS, Kim HA, Seong MK, Seol H, Oh JS, Kim EK, Chang JW, Hwang SG, Noh WC. 2016. STAT3-survivin signaling mediates a poor response to radiotherapy in HER2-positive breast cancers. Oncotarget. 7(6):7055–7065.
   PubMedGoogle Scholar
• Kim SC, Shin YK, Kim YA, Jang SG, Ku JL. 2018. Identification of genes inducing resistance to ionizing radiation in human rectal cancer cell lines: re-sensitization of radio-resistant rectal cancer cells through down regulating NDRG1. BMC Cancer. 18(1):594.
   PubMedGoogle Scholar
• Koukourakis MI. 2012. Radiation damage and radioprotectants: new concepts in the era of molecular medicine. Br J Radiol. 85(1012):313–330.
   PubMed Web of Science ®Google Scholar
• Kühnel A, Schilling D, Combs SE, Haller B, Schwab M, Multho G. 2019. Radiosensitization of HSF-1 knockdown lung cancer cells by low concentrations of Hsp90 inhibitor NVP-AUY922. Cells. 8(10):1166.
   Web of Science ®Google Scholar
• Kumar V, Vashishta M, Kong L, Wu X, Lu JJ, Guha C, Dwarakanath BS. 2021. The role of notch, hedgehog, and Wnt signaling pathways in the resistance of tumors to anticancer therapies. Front Cell Dev Biol. 9:650772.
   PubMed Web of Science ®Google Scholar
• Lämmer F, Delbridge C, Würstle S, Neff F, Meyer B, Schlegel J, Kessel KA, Schmid TE, Schilling D, Stephanie E, et al. 2019. Cytosolic Hsp70 as a biomarker to predict clinical outcome in patients with glioblastoma. PLoS One. 14(8):e0221502.
   PubMed Web of Science ®Google Scholar
• Leith JT, Mousa SA, Hercbergs A, Lin HY, Davis PJ. 2018. Radioresistance of cancer cells, integrin αvβ3 and thyroid hormone. Oncotarget. 9(97):37069–37075.
   PubMedGoogle Scholar
• Li N, Meng DD, Gao L, Xu Y, Liu PJ, Tian YW, Yi ZY, Zhang Y, Tie XJ, Xu ZQ. 2018. Overexpression of HOTAIR leads to radioresistance of human cervical cancer via promoting HIF-1α expression. Radiat Oncol. 13(1):210.
   PubMedGoogle Scholar
• Lyakhovich A, Lleonart ME. 2016. Bypassing mechanisms of mitochondria-mediated cancer stem cells resistance to chemo- and radiotherapy. Oxid Med Cell Longev. 2016:1716341.
   PubMed Web of Science ®Google Scholar
• Lynam-Lennon N, Heavey S, Sommerville G, Bibby BAS, Ffrench B, Quinn J, Gasch C, O'Leary JJ, Gallagher MF, Reynolds JV, et al. 2017. MicroRNA-17 is downregulated in esophageal adenocarcinoma cancer stem-like cells and promotes a radioresistant phenotype. Oncotarget. 8(7):11400–11413.
   PubMed Web of Science ®Google Scholar
• Lynam-Lennon N, Maher SG, Maguire A, Phelan J, Muldoon C, Reynolds JV, O'Sullivan J. 2014. Altered mitochondrial function and energy metabolism is associated with a radioresistant phenotype in oesophageal adenocarcinoma. PLoS One. 9(6):e100738.
   PubMed Web of Science ®Google Scholar
• Ma Y, Shen N, Wicha MS, Luo M. 2021. The roles of the Let-7 family of microRNAs in the regulation of cancer stemness. Cells. 10(9):2415.
   PubMed Web of Science ®Google Scholar
• McDermott N, Meunier A, Mooney B, Nortey G, Hernandez C, Hurley S, Lynam-Lennon N, Barsoom SH, Bowman KJ, Marples B, et al. 2016. Fractionated radiation exposure amplifies the radioresistant nature of prostate cancer cells. Sci Rep. 6:34796.
   PubMed Web of Science ®Google Scholar
• Mercado-Sáenz S, López-Díaz B, Sendra-Portero F, Martínez-Morillo M, Ruiz-Gómez MJ. 2017. Inactivation of RAD52 and HDF1 DNA repair genes leads to premature chronological aging and cellular instability. J Biosci. 42(2):219–230.
   PubMed Web of Science ®Google Scholar
• Moreno M, Pedrosa L, Paré L, Pineda E, Bejarano L, Martínez J, Balasubramaniyan V, Ezhilarasan R, Kallarackal N, Kim S8, et al. 2017. GPR56/ADGRG1 inhibits mesenchymal differentiation and radioresistance in glioblastoma. Cell Rep. 21(8):2183–2197.
   PubMed Web of Science ®Google Scholar
• Muschter D, Geyer F, Bauer R, Ett T, Schrem S, Haubner F. 2018. A comparison of cell survival and heat shock protein expression after radiation in normal dermal fibroblasts, microvascular endothelial cells, and different head and neck squamous carcinoma cell lines. Clin Oral Investig. 22(6):2251–2262.
   PubMed Web of Science ®Google Scholar
• Nguyen HS, Shabani S, Awad AJ, Kaushal M, Doan N. 2018. Molecular markers of therapy-resistant glioblastoma and potential strategy to combat resistance. IJMS. 19(6):1765.
   Google Scholar
• Nie X, Guo E, Wu C, Liu D, Sun W, Zhang L, Long G, Mei Q, Wu K, Xiong H, et al. 2019. SALL4 induces radioresistance in nasopharyngeal carcinoma via the ATM/Chk2/p53 pathway . Cancer Med. 8(4):1779–1792.
   PubMed Web of Science ®Google Scholar
• Orth M, Albrecht V, Seidl K, Kinzel L, Unger K, Hess J, Kreutzer L, Sun N, Stegen B, Nieto A, et al. 2021. Inhibition of HSP90 as a strategy to radiosensitize glioblastoma: targeting the DNA damage response and beyond. Front Oncol. 11:612354.
   PubMed Web of Science ®Google Scholar
• Pan X, Lin Z, Jiang D, Yu Y, Yang D, Zhou H, Zhan D, Liu S, Peng G, Chen Z, et al. 2019. Erastin decreases radioresistance of NSCLC cells partially by inducing GPX4-mediated ferroptosis. Oncol Lett. 17(3):3001–3008.
   PubMed Web of Science ®Google Scholar
• Pérez-Añorve IX, Gonzalez-De la Rosa CH, Soto-Reyes E, Beltran-Anaya FO, Del Moral-Hernandez O, Salgado-Albarran M, Angeles-Zaragoza O, Gonzalez-Barrios JA, Landero-Huerta DA, Chavez-Saldaña M, et al. 2019. New insights into radioresistance in breast cancer identify a dual function of miR-122 as a tumor suppressor and oncomiR. Mol Oncol. 13(5):1249–1267.
   PubMed Web of Science ®Google Scholar
• Phan LM, Rezaeian AH. 2021. ATM: main features, signaling pathways, and its diverse roles in DNA damage response, tumor suppression, and cancer development. Genes. 12(6):845.
   PubMed Web of Science ®Google Scholar
• Phillips RM, Lam C, Wang H, Tran PT. 2019. Bittersweet tumor development and progression: emerging roles of epithelial plasticity glycosylations. Adv Cancer Res. 142:23–62.
   PubMed Web of Science ®Google Scholar
• Piotto C, Biscontin A, Millino C, Mognato M. 2018. Functional validation of miRNAs targeting genes of DNA double-strand break repair to radiosensitize non-small lung cancer cells . Biochim Biophys Acta Gene Regul Mech. 1861(12):1102–1118.
   PubMed Web of Science ®Google Scholar
• Qu C, Zhao Y, Feng G, Chen C, Tao Y, Zhou S, Liu S, Chang H, Zeng M, Xia Y. 2017. RPA3 is a potential marker of prognosis and radioresistance for nasopharyngeal carcinoma. J Cell Mol Med. 21(11):2372–2383.
   Web of Science ®Google Scholar
• Rajesh Y, Biswas A, Banik P, Pal I, Das S, Borkar SA, Sardana H, Saha A, Das SK, Emdad L, et al. 2020. Transcriptional regulation of HSPB1 by Friend leukemia integration-1 factor modulates radiation and temozolomide resistance in glioblastoma. Oncotarget. 11(13):1097–1108.
   PubMedGoogle Scholar
• Rajesh Y, Biswas A, Mandal M. 2017. Glioma progression through the prism of heat shock protein mediated extracellular matrix remodeling and epithelial to mesenchymal transition. Exp Cell Res. 359(2):299–311.
   PubMed Web of Science ®Google Scholar
• Rauth S, Karmakar S, Shah A, Seshacharyulu P, Nimmakayala RK, Ganguly K, Bhatia R, Muniyan S, Kumar S, Dutta S, et al. 2021. SUMO modification of PAF1/PD2 enables PML interaction and promotes radiation resistance in pancreatic ductal adenocarcinoma. Mol Cell Biol. 41(12):e0013521.
   PubMed Web of Science ®Google Scholar
• Roche KC, Gracz AD, Liu XF, Newton V, Akiyama H, Magness ST. 2015. SOX9 maintains reserve stem cells and preserves radioresistance in mouse small intestine. Gastroenterology . 149(6):1553–1563.
   PubMed Web of Science ®Google Scholar
• Sabaawy HE, Ryan BM, Khiabanian H, Pine SR. 2021. JAK/STAT of all trades: linking inflammation with cancer development, tumor progression and therapy resistance. Carcinogenesis. 42(12):1411–1419.
   PubMed Web of Science ®Google Scholar
• Shrivastava S, Mansure JJ, Almajed W, Cury F, Ferbeyre G, Popovic M, Seuntjens J, Kassouf W. 2016. The role of HMGB1 in radioresistance of bladder cancer. Mol Cancer Ther. 15(3):471–479.
   PubMed Web of Science ®Google Scholar
• Sishc BJ, Ding L, Nam TK, Heer CD, Rodman SN, Schoenfeld JD, Fath MA, Saha D, Pulliam CF, Langen B, et al. 2021. Avasopasem manganese synergizes with hypofractionated radiation to ablate tumors through the generation of hydrogen peroxide. Sci Transl Med. 13(593): eabb3768.
   PubMed Web of Science ®Google Scholar
• Slavik M, Shatokhina T, Sana J, Ahmad P, Kazda T, Selingerova I, Hermanova M, Cervena R, Novotny T, Burkon P, et al. 2019. Expression of CD44, EGFR, p16, and their mutual combinations in patients with head and neck cancer: impact on outcomes of intensity-modulated radiation therapy. Head Neck. 41(4):940–949.
   PubMed Web of Science ®Google Scholar
• Takaoka Y, Konno M, Koseki J, Colvin H, Asai A, Tamari K, Satoh T, Mori M, Doki Y, Ogawa K, et al. 2019. Mitochondrial pyruvate carrier 1 expression controls cancer epithelial-mesenchymal transition and radioresistance. Cancer Sci. 110(4):1331–1339.
   PubMed Web of Science ®Google Scholar
• Tang L, Wei F, Wu Y, He Y, Shi L, Xiong F, Gong Z, Guo C, Li X, Deng H, et al. 2018. Role of metabolism in cancer cell radioresistance and radiosensitization methods. J Exp Clin Cancer Res. 37(1):87.
   PubMedGoogle Scholar
• Troschel FM, Böhly N, Borrmann K, Braun T, Schwickert A, Kiesel L, Eich HT, Götte M, Greve B. 2018. miR-142-3p attenuates breast cancer stem cell characteristics and decreases radioresistance in vitro. Tumour Biol. 40(8):1010428318791887.
   Google Scholar
• Tsubouchi K, Minami K, Hayashi N, Yokoyama Y, Mori S, Yamamoto H, Koizumi M. 2017. The CD44 standard isoform contributes to radioresistance of pancreatic cancer cells. J Radiat Res. 58(6):816–826.
   PubMed Web of Science ®Google Scholar
• Wang Y, Gudikote J, Giri U, Yan J, Deng W, Ye R, Jiang W, Li N, Hobbs BP, Wang J, et al. 2018. RAD50 expression is associated with poor clinical outcomes after radiotherapy for resected non-small cell lung cancer. Clin Cancer Res. 24(2):341–350.
   PubMed Web of Science ®Google Scholar
• Wu X, Tang W, Marquez RT, Li K, Highfill CA, He F, Lian J, Lin J, Fuchs JR, Ji M, et al. 2016. Overcoming chemo/radio-resistance of pancreatic cancer by inhibiting STAT3 signaling. Oncotarget. 7(10):11708–11723.
   PubMedGoogle Scholar
• Yokota Y, Sakamoto AN. 2018. The moss Physcomitrella patens is hyperresistant to DNA double-strand breaks induced by γ-irradiation. Genes. 9(2):76.
   Web of Science ®Google Scholar
• You GR, Cheng AJ, Lee LY, Huang YC, Liu H, Chen YJ, Chang JT. 2019. Prognostic signature associated with radioresistance in head and neck cancer via transcriptomic and bioinformatic analyses. BMC Cancer. 19(1):64.
   PubMedGoogle Scholar
• Yun HS, Baek JH, Yim JH, Um HD, Park JK, Song JY, Park IC, Kim JS, Lee SJ, Lee CW, et al. 2016. Radiotherapy diagnostic biomarkers in radioresistant human H460 lung cancer stem-like cells. Cancer Biol Ther. 17(2):208–218.
   PubMed Web of Science ®Google Scholar
• Yun EJ, Lin CJ, Dang A, Hernandez E, Guo J, Chen WM, Allison J, Kim N, Kapur P, Brugarolas J, et al. 2019. Downregulation of human DAB2IP gene expression in renal cell carcinoma results in resistance to ionizing radiation. Clin Cancer Res. 25(14):4542–4551.
   PubMed Web of Science ®Google Scholar
• Zang C, Zhao F, Hua L, Pu Y. 2018. The miR-199a-3p regulates the radioresistance of esophageal cancer cells via targeting the AK4 gene. Cancer Cell Int. 18:186.
   PubMed Web of Science ®Google Scholar
• Zhang G, Wang W, Yao C, Zhang S, Liang L, Han M, Ren J, Qi X, Zhang X, Wang S, et al. 2017. Radiation-resistant cancer stem-like cell properties are regulated by PTEN through the activity of nuclear β-catenin in nasopharyngeal carcinoma . Oncotarget. 8(43):74661–74672.
   PubMedGoogle Scholar
• Zhao W, Sun M, Li S, Chen Z, Geng D. 2018. Transcription factor ATF3 mediates the radioresistance of breast cancer. J Cell Mol Med. 22(10):4664–4675.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Tao L, Yi J, Song H, Chen L. 2018. The role of canonical Wnt signaling in regulating radioresistance. Cell Physiol Biochem. 48(2):419–432.
   PubMedGoogle Scholar
• Zhong Q, Liu ZH, Lin ZR, Hu ZD, Yuan L, Liu YM, Zhou AJ, Xu LH, Hu LJ, Wang ZF, et al. 2018. The RARS-MAD1L1 fusion gene induces cancer stem cell-like properties and therapeutic resistance in nasopharyngeal carcinoma. Clin Cancer Res. 24(3):659–673.
   PubMed Web of Science ®Google Scholar